Tumor budding as a novel predictor of occult metastasis in cT2N0 tongue squamous cell carcinoma

Tumor budding as a novel predictor of occult metastasis in cT2N0 tongue squamous cell carcinoma Occult neck metastasis is an important prognostic factor in patients with tongue squamous cell carcinoma (TSCC) who are deemed clinically negative for neck metastasis. The purpose of this study was to identify predictive factors for occult neck metastasis arising from TSCC and to determine patient prognosis. Ninety-seven patients with cT2N0 TSCC who underwent surgical resection of their primary lesion as initial therapy were enrolled in this retrospective study. Cutoff values for depth of invasion (≥3.3 mm) and the tumor budding score (≥4) were determined using receiver operator characteristic analyses. Univariate and multivariate analyses revealed that a tumor budding score ≥4 is a significant independent predictive factor for the occurrence of occult neck metastasis, which in turn is a significant independent prognostic factor. When evaluating tumor budding, we demonstrated greater interobserver and intraobserver agreement when using immunohistochemical staining for cytokeratin AE1/AE3 than with hematoxylin and eosin staining (HE). We conclude that the evaluation of tumor budding is effective for identifying populations at high risk of occult neck metastasis, which will enable the planning of appropriate therapeutic strategies for patients with cT2N0 TSCC. Furthermore, cytokeratin staining is recommended over HE staining for simpler and more accurate evaluation of tumor budding. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Human Pathology Elsevier

Tumor budding as a novel predictor of occult metastasis in cT2N0 tongue squamous cell carcinoma

8 pages
Read Article

Loading next page...
1
 
/lp/elsevier/tumor-budding-as-a-novel-predictor-of-occult-metastasis-in-ct2n0-j4XjCI8P1e
Publisher
Elsevier
Copyright
Copyright © 2018 Elsevier Inc.
ISSN
0046-8177
DOI
10.1016/j.humpath.2017.12.021
Publisher site
See Article on Publisher Site

Abstract

Occult neck metastasis is an important prognostic factor in patients with tongue squamous cell carcinoma (TSCC) who are deemed clinically negative for neck metastasis. The purpose of this study was to identify predictive factors for occult neck metastasis arising from TSCC and to determine patient prognosis. Ninety-seven patients with cT2N0 TSCC who underwent surgical resection of their primary lesion as initial therapy were enrolled in this retrospective study. Cutoff values for depth of invasion (≥3.3 mm) and the tumor budding score (≥4) were determined using receiver operator characteristic analyses. Univariate and multivariate analyses revealed that a tumor budding score ≥4 is a significant independent predictive factor for the occurrence of occult neck metastasis, which in turn is a significant independent prognostic factor. When evaluating tumor budding, we demonstrated greater interobserver and intraobserver agreement when using immunohistochemical staining for cytokeratin AE1/AE3 than with hematoxylin and eosin staining (HE). We conclude that the evaluation of tumor budding is effective for identifying populations at high risk of occult neck metastasis, which will enable the planning of appropriate therapeutic strategies for patients with cT2N0 TSCC. Furthermore, cytokeratin staining is recommended over HE staining for simpler and more accurate evaluation of tumor budding.

Journal

Human Pathology – Elsevier

Published: Jun 1, 2018

References

  • Cancer Statistics, 2017
    Siegel, R.L.; Miller, K.D.; Jemal, A.
  • Management of the N0 neck in early cancer of the oral tongue
    Yii, N.W.; Patel, S.G.; Rhys-Evans, P.H.; Breach, N.M.
  • Prediction of delayed neck metastasis in patients with stage I/II squamous cell carcinoma of the tongue
    Okamoto, M.; Nishimine, M.; Kishi, M.
  • Elective versus therapeutic neck dissection in node-negative oral cancer
    D'Cruz, A.K.; Vaish, R.; Kapre, N.
  • AJCC cancer staging manual
    Edge, S.B.; Byrd, D.R.; Compton, C.C.
  • Early stage squamous cell cancer of the oral tongue--clinicopathologic features affecting outcome
    Ganly, I.; Patel, S.; Shah, J.
  • Risk factors for late cervical lymph node metastases in patients with stage I or II carcinoma of the tongue
    Kurokawa, H.; Yamashita, Y.; Takeda, S.; Zhang, M.; Fukuyama, H.; Takahashi, T.
  • Multivariate predictors of occult neck metastasis in early oral tongue cancer
    Sparano, A.; Weinstein, G.; Chalian, A.; Yodul, M.; Weber, R.
  • AJCC cancer staging manual
    Amin, M.B.; Edge, S.B.; Greene, F.L.
  • A new prognostic staging system for rectal cancer
    Ueno, H.; Price, A.B..; Wilkinson, K.H.; Jass, J.R.; Mochizuki, H.; Talbot, I.C.
  • Systematic review and meta-analysis of the impact of tumour budding in colorectal cancer
    Rogers, A.C.; Winter, D.C.; Heeney, A.
  • Tumor budding in tumor invasive front predicts prognosis and survival of patients with esophageal squamous cell carcinomas receiving neoadjuvant chemotherapy
    Miyata, H.; Yoshioka, A.; Yamasaki, M.
  • Tumor budding is an independent adverse prognostic factor in pancreatic ductal adenocarcinoma
    O'Connor, K.; Li-Chang, H.H.; Kalloger, S.E.
  • Characterization of the immunophenotype of the tumor budding and its prognostic implications in squamous cell carcinoma of the lung
    Taira, T.; Ishii, G.; Nagai, K.
  • Cytokeratin immunohistochemistry improves interobserver variability between unskilled pathologists in the evaluation of tumor budding in T1 colorectal cancer
    Kai, K.; Aishima, S.; Aoki, S.
  • Pathology and Genetics of Head and Neck Tumours
    Barnes, L.; Eveson, J.W.; Reichart, P.
  • General rules for clinical and pathological studies on oral cancer: a synopsis
    Izumo, T.; Kirita, T.; Ariji, E.
  • The protective effect of p16(INK4a) in oral cavity carcinomas: p16(Ink4A) dampens tumor invasion-integrated analysis of expression and kinomics pathways
    Isayeva, T.; Xu, J.; Ragin, C.
  • The pathological significance of Notch1 in oral squamous cell carcinoma
    Yoshida, R.; Nagata, M.; Nakayama, H.
  • Tumour budding in colorectal carcinoma
    Prall, F.
  • An application of hierarchical κ-type statistics in the assessment of majority agreement among multiple observers
    Landis, J.R.; Koch, G.G.
  • Improved survival for patients with clinically T1/T2, N0 tongue tumors undergoing a prophylactic neck dissection
    Haddadin, K.J.; Soutar, D.S.; Oliver, R.J.; Webster, M.H.; Robertson, A.G.; MacDonald, D.G.
  • Elective neck treatment versus observation in patients with T1/T2 N0 squamous cell carcinoma of oral tongue
    Keski-Santti, H.; Atula, T.; Tornwall, J.; Koivunen, P.; Makitie, A.
  • NCCN Clinical Practice Guidelines in Oncology: Head and Neck Cancers
    National Comprehensive Cancer Network
  • Predictive value of tumor thickness for cervical lymph-node involvement in squamous cell carcinoma of the oral cavity: a meta-analysis of reported studies
    Huang, S.H.; Hwang, D.; Lockwood, G.; Goldstein, D.P.; O'Sullivan, B.
  • Reproducibility, repeatability, and level of difficulty of two methods for tumor budding evaluation in oral squamous cell carcinoma
    Leao, P.L.R.; Marangon Junior, H.; Melo, V.V.M.
  • Histologic assessment of tumor budding in preoperative biopsies to predict nodal metastasis in squamous cell carcinoma of the tongue and floor of the mouth
    Seki, M.; Sano, T.; Yokoo, S.; Oyama, T.
  • Tumor budding is an independent prognostic factor for prediction of lymph node metastasis in oral squamous cell carcinoma
    Angadi, P.V.; Patil, P.V.; Hallikeri, K.; Mallapur, M.D.; Hallikerimath, S.; Kale, A.D.
  • Tumor budding, a novel prognostic indicator for predicting stage progression in T1 bladder cancers
    Fukumoto, K.; Kikuchi, E.; Mikami, S.
  • A simple novel prognostic model for early stage oral tongue cancer
    Almangush, A.; Coletta, R.D.; Bello, I.O.
  • Prognostic value of tumour budding in oesophageal cancer: a meta-analysis
    Almangush, A.; Karhunen, M.; Hautaniemi, S.; Salo, T.; Leivo, I.
  • Tumor budding as a prognostic marker in laryngeal carcinoma
    Sarioglu, S.; Acara, C.; Akman, F.C.
  • Tumour budding and the expression of cancer stem cell marker aldehyde dehydrogenase 1 in nasopharyngeal carcinoma
    Luo, W.R.; Gao, F.; Li, S.Y.; Yao, K.T.
  • Predictive significance of tumor depth and budding for late lymph node metastases in patients with clinical n0 early oral tongue carcinoma
    Hori, Y.; Kubota, A.; Yokose, T.
  • Tumor budding correlates with occult cervical lymph node metastasis and poor prognosis in clinical early-stage tongue squamous cell carcinoma
    Xie, N.; Wang, C.; Liu, X.

You’re reading a free preview. Subscribe to read the entire article.

Try 2 weeks free now

DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

or browse the journals available

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create folders to
organize your research

Export folders, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off

Sign up
for free
Start 14 day
Free Trial